Streetbeat News

Partnerships

AORT

BAX

Artivion has secured FDA PMA approval for PerClot and will transfer the PMA to Baxter. Artivion will receive a milestone payment of $18.75 million, with $4.5 million paid to its former partner Starch Medical, Inc.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 12:07 pm

AORT

BAX

Artivion announced FDA PMA approval of PerClot, a hemostatic system for controlling bleeding in surgical procedures. Artivion sold the product line to Baxter in July 2021 and will transfer the PMA to Baxter following approval. Baxter will pay a milestone payment of $18.75 million, with $4.5 million going to Artivion's former partner Starch Medical.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 12:05 pm

QUBT

Quantum Computing Inc. (QCI) has received a follow-on task order to its subcontract award to support NASA in remote sensing and climate change monitoring. QCI will test its QLiDAR system and process satellite images using its photonic-based reservoir computing technology.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 12:05 pm

J

Jacobs Engineering Group Inc. has secured a $249 million contract to manage architecture and engineering services for the US Navy in the Southwest region.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 11:51 am

MSFT

SPNS

Sapiens International Corporation (SPNS) announced an agreement to integrate Microsoft Azure OpenAI Service and Azure Power Virtual Agents into its insurance software solutions, aiming to enhance customer experience and streamline operations.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 11:26 am

HLNE

Hamilton Lane has raised over $850 million with the close of its second impact fund, expanding its sustainable investment platform. The fund will focus on investments that generate positive environmental, social, and governance (ESG) outcomes.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 11:14 am

VEEV

UCB and Veeva Systems have announced a partnership to improve patient experience in clinical trials. The collaboration aims to streamline data collection and enhance patient engagement using Veeva's technology.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 11:09 am

ATOS

Societal CDMO has entered an agreement with Atossa Therapeutics to provide clinical trial services for Atossa's selective estrogen receptor modulator. This partnership aims to advance Atossa's drug development program.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 11:04 am

MCLD

mCloud Technologies has formed a special committee to explore strategic alternatives for the company's future.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 11:03 am

UEC

Uranium Energy Corp (NYSE:UEC) has selected SLR Consulting and Wood to conduct an S-K 1300 Initial Assessment Economic Study for its 100% owned Roughrider Project in Saskatchewan, Canada. CanNorth will conduct environmental baseline work for the project.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 10:57 am